Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra

Clinical trial NCT01259219 · UNKNOWN

Trial details

NCT number: NCT01259219
Sponsor: Harriet Shezi Children's Clinic
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Children With Confirmed HIV Infection Receiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard Dose Successfully Completed TB Treatment in the Past 2 to 6 Weeks of Enrollment

Start date: 2010-11-01
Primary completion: 2011-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.